PART I Overview Unless otherwise noted or required by context, use of Assertio, the Company, we, our and us refer to Assertio Holdings and/or its applicable subsidiary or subsidiaries. Reference to Assertio Specialty refers to Assertio Specialty Pharmaceuticals, LLC, and Spectrum refers to Spectrum Pharmaceuticals, Inc. and/or its applicable subsidiary or subsidiaries. Both Assertio Specialty and Spectrum are wholly-owned subsidiaries of the Company. Additionally, the use of Assertio Therapeutic...
Q2 FY2026 — expected 2026-08-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001808665-26-000011 | EDGAR | 64K words |
| 2025-03-12 | 2024-12-31 | 0001808665-25-000009 | EDGAR | — |
| 2024-03-11 | 2023-12-31 | 0001808665-24-000012 | EDGAR | — |
| 2023-03-08 | 2022-12-31 | 0001808665-23-000019 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001808665-22-000012 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001808665-21-000019 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001808665-25-000036 | EDGAR | 24K words |
| 2025-08-11 | 2025-06-30 | 0001808665-25-000026 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001808665-25-000014 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001808665-24-000042 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001808665-24-000035 | EDGAR | — |
| 2024-05-06 | 2024-03-31 | 0001808665-24-000023 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001808665-23-000065 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001808665-23-000053 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001808665-23-000033 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001808665-22-000066 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001808665-22-000048 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001808665-22-000032 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001808665-26-000010 | EDGAR | 7K words |
| 2026-01-12 | 0001104659-26-002899 | EDGAR | — |
| 2025-12-22 | 0001104659-25-123772 | EDGAR | — |
| 2025-11-21 | 0001104659-25-115051 | EDGAR | — |
| 2025-11-10 | 0001808665-25-000034 | EDGAR | — |
| 2025-10-30 | 0001104659-25-104439 | EDGAR | — |
| 2025-10-10 | 0001104659-25-098758 | EDGAR | — |
| 2025-08-11 | 0001808665-25-000024 | EDGAR | — |
| 2025-05-13 | 0001104659-25-047861 | EDGAR | — |
| 2025-05-12 | 0001808665-25-000011 | EDGAR | — |
105 total filings indexed. 77 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001808665 |
| Ticker | ASRT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.assertiotx.com |
| Listed | 1997-11-05 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report